France· FR:63679504
TIVICAY 25 mg, comprimé pelliculé
A medicinal product containing dolutégravir sodique, registered in France by VIIV HEALTHCARE (PAYS-BAS), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- DOLUTÉGRAVIR SODIQUE
- Manufacturer
- VIIV HEALTHCARE (PAYS-BAS)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400930085462flacon(s) polyéthylène haute densité (PEHD) de 30 comprimé(s) avec fermeture de sécurité enfantEUR 235.35
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dolutégravir sodique in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenDogrivio 25 mg Filmdragerad tablettElpen Pharmaceutical Co. Inc
- United StatesTivicayViiV Healthcare Company
- CzechiaTIVICAYViiV Healthcare BV, Amersfoort
- IrelandTivicay 25 mg film-coated tabletsViiV Healthcare BV
- BelgiumTivicay 25 mgViiV Healthcare
- NetherlandsTivicay 25 mg, filmomhulde tabletViiV healthcare B.V.
- PolandTivicayViiV Healthcare BV
- IcelandTivicayViiV Healthcare BV
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- Cyprus · Dogrivio
- Iceland · Tivicay
- Liechtenstein · Tivicay
- Norway · Dolutegravir Teva, Tivicay
- Sweden · Dogrivio, Dolutegravir Elpen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4a491906-c1d8-4aa8-86ec-c0eef5b3e8c4 GET /v1/drugs/4a491906-c1d8-4aa8-86ec-c0eef5b3e8c4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "63679504",
"date_amm": "2017-02-23",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/13/892",
"substance": "DOLUTÉGRAVIR SODIQUE",
"statut_amm": "Autorisation active",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about dolutégravir sodique.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.